In addition, the combination of PFTS and phospho-valproic acid, a new STAT3 (signal transducer and activator of transcription 3) inhibitor, has been shown to exhibit synergistic effects in pancreatic cancer. This evidence concerns the gene STAT3 and familial pancreatic carcinoma.